Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Exelixis Inc. (EXEL)

NASDAQ

$57,00

$+0,01

(+0,02%)

Pre-Market

Exelixis Inc. (EXEL) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Exelixis Inc. (EXEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $57,00, with a market capitalisation of $13,93B and a P/E ratio of 16,38. Over the past 52 weeks, its price has ranged from $33,76 to $59,72. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13,93B
Open	$56,99
Day's High	$999,99
Day's Low	$1,26
Previous Close	$56,90
Volume	5,20K
Average Volume	2,55M
P/E Ratio	16,38
52-Week High	$59,72
52-Week Low	$33,76
Dividend Yield	--
Earnings Date	--

Exelixis Inc. (EXEL) Pre-Market Stock Price

Exelixis Inc. (EXEL) is trading at $57,00 in pre-market trading as of 2026-09-16 08:57:00, up 0,18% ($0,10) from the previous close of $56,90

Pre-market trading shows how investors are pricing EXEL before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

Exelixis Inc. (EXEL) 7-Day Stock Price Change

Over the past seven days, Exelixis Inc. (EXEL) moved from $59,01 to $57,00, representing a decline of 3,40% ($2,01).

The stock traded between $53,94 and $59,41 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 2,05 million shares, down versus the previous seven-day period, indicating lower trading activity.

EXEL 52-Week Price Position

Position in Range: 89,5%

52W Low$33,76

52W High$59,72

EXEL is currently trading at $57,00, placing it 89,5% of the way from its 52-week low of $33,76 to its 52-week high of $59,72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Exelixis Inc. (EXEL)?

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	1077
Exchange	NASDAQ
Company Website	https://www.exelixis.com

How to Buy Exelixis Inc. (EXEL) Stock on MEXC

Eligible investors can buy real shares of Exelixis Inc. (EXEL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EXEL and Place Your Order

Open the RealStocks trading page and search for EXEL. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Exelixis Inc. (EXEL) stock price today?

Exelixis Inc. (EXEL) is currently trading at $ 57,00, up 0,18% ($0,10) from the previous close of $ 56,90. Intraday prices update in real time during regular trading hours.

2.Is EXEL stock going up or down today?

As of 2026-09-16 08:57:00, EXEL is trading at $ 57,00, up 0,18% ($0,10) from its previous close of $ 56,90. The stock has traded between $ 1,26 and $ 999,99 during today’s regular session. Past price movements do not guarantee future results.

3.What is EXEL pre-market price?

As of 2026-09-16 08:57:00, EXEL is trading at $ 57,00 in pre-market trading, up 0,18% ($0,10) from the previous close of $ 56,90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EXEL after-hours price?

As of 2026-09-16 08:57:00, EXEL is trading at $ 56,99 in after-hours trading, up 0,15% ($0,09) from the regular-session close of $ 56,90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EXEL stock trading now?

EXEL trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EXEL sit relative to its 52-week high and low?

Over the past 52 weeks, EXEL has traded between a low of $ 33,76 and a high of $ 59,72. At $ 57,00, the stock is positioned 89,5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Exelixis Inc. in?

Exelixis Inc. (EXEL) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Exelixis Inc.'s market capitalisation and where is it listed?

Exelixis Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 13,93B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EXEL valued in terms of P/E ratio and EPS?

EXEL trades at a P/E ratio of 16,38, based on trailing-twelve-month EPS of $ 3,47. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Exelixis Inc. pay a dividend?

Exelixis Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.